Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Compassionate Use of Nitazoxanide for the Treatment of Clostridium Difficile Colitis in Patients Who Have Failed Conventional Therapy

NCT00304356 is registered in ClinicalTrials.gov with Daniel M. Musher MD as lead sponsor.

NCT NCT00304356
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00304356 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Compassionate Use of Nitazoxanide for the Treatment of Clostridium Difficile Colitis in Patients Who Have Failed Conventional Therapy
Lead sponsor
Daniel M. Musher MD
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2004
Completion date
January 31, 2007
Enrollment
22 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

clostridium enterocolitis, pseudomembranous colitis